← Open Payments lookup

TOBY KARYADI: Open Payments

NPI 1013170422 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,193 in 58 payments from 16 companies in 2025. Trend: 2023 $946 · 2024 $1,435 · 2025 $1,193

Food & beverage: $1,193
CompanyPaymentsAmount
ABBVIE INC.16$238
Novo Nordisk Inc10$238
Lilly USA, LLC5$114
AstraZeneca Pharmaceuticals LP5$110
Boehringer Ingelheim Pharmaceuticals, Inc.3$83
Exact Sciences Corporation3$70
Abbott Laboratories3$66
Merck Sharp & Dohme LLC3$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$35

Products named: QULIPTA, UBRELVY, JARDIANCE, MOUNJARO, Wegovy, Ozempic, FREESTYLE LIBRE 3, GARDASIL 9.

Industry payments across MD — which companies pay providers there.